Christopher Causey, Director at UNITED THERAPEUTICS Corp (UTHR), sold 3,000 shares at $430.00 ($1.3M) on 2025-09-02, disclosed to the SEC on 2025-09-02.
Scheduled sale ($1.3M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $419.63 | 1,000 | $420K | 33.1% |
| 2 | $420.00 | 1,000 | $420K | 33.1% |
| 3 | $430.00 | 1,000 | $430K | 33.9% |
| Total | $423.21 avg | 3,000 | $1.3M | 100% |
| Filing → |
| UTHR | SELL | 2026-02-25 | $520K | — | Filing → |
| UTHR | SELL | 2026-01-06 | $510K | — | Filing → |
| UTHR | SELL | 2026-01-05 | $500K | — | Filing → |